90 related articles for article (PubMed ID: 9054575)
1. Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.
Lampidis TJ; Kolonias D; Podona T; Israel M; Safa AR; Lothstein L; Savaraj N; Tapiero H; Priebe W
Biochemistry; 1997 Mar; 36(9):2679-85. PubMed ID: 9054575
[TBL] [Abstract][Full Text] [Related]
2. N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
Lothstein L; Hosey LM; Sweatman TW; Koseki Y; Dockter M; Priebe W
Oncol Res; 1993; 5(6-7):229-34. PubMed ID: 7907237
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.
Zhao JY; Savaraj N; Song R; Priebe W; Kuo MT
Anticancer Res; 1994; 14(5A):1735-42. PubMed ID: 7531410
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
5. Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase II.
Beck WT
Bull Cancer; 1990; 77(11):1131-41. PubMed ID: 1980425
[TBL] [Abstract][Full Text] [Related]
6. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH
Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877
[TBL] [Abstract][Full Text] [Related]
8. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
9. Anthracyclines.
Sinha BK; Politi PM
Cancer Chemother Biol Response Modif; 1990; 11():45-57. PubMed ID: 2223402
[TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
11. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
12. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
[TBL] [Abstract][Full Text] [Related]
13. N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells.
Lothstein L; Wright HM; Sweatman TW; Israel M
Oncol Res; 1992; 4(8-9):341-7. PubMed ID: 1362503
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers.
Safa AR
Drug Resist Updat; 1999 Dec; 2(6):371-381. PubMed ID: 11498353
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
16. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.
Serafino A; Sinibaldi-Vallebona P; Gaudiano G; Koch TH; Rasi G; Garaci E; Ravagnan G
Anticancer Res; 1998; 18(2A):1159-66. PubMed ID: 9615782
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
Frézard F; Pereira-Maia E; Quidu P; Priebe W; Garnier-Suillerot A
Eur J Biochem; 2001 Mar; 268(6):1561-7. PubMed ID: 11248673
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline resistance: the problem and its current definition.
Gianni L
Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-11-S10-17. PubMed ID: 9275001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]